LGC acquires LINK and strengthens its oligo reagents offering

News - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis

19 July 2017
LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

News - Moves strengthen existing analytical and bioanalytical drug development service offering

03 April 2017
Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

News - Funding to develop liver targeted gene activation therapies

02 November 2017